Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over yearQ1 2025 revenue from continuing operations of…
Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies,…
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann…
Collaboration aims to enhance clinical study experience and accelerate therapeutic innovation for arrhythmogenic cardiomyopathy caused by PKP2 mutations SAN FRANCISCO…
BOULDER, Colo., May 7, 2025 /PRNewswire/ -- CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced that qCal-MR®, an…
LSU LCMC Health Cancer Center joins the exclusive network of leading cancer institutions utilizing data to improve patient outcomes …
Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB)…
BERKELEY HEIGHTS, NJ, May 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”),…
HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…
Participants treated with gildeuretinol in the SAGA study in geographic atrophy (GA) secondary to age-related macular degeneration (AMD) showed a…